New study finds mRNA vaccine helps battle against melanoma
Researchers have been experimenting with mRNA for decades as a potential weapon against cancer, but they haven't had much luck -- until now. In a new study, scientists tested two groups of melanoma patients. They found nearly 79% of patients had no recurrence after 18 months when given a personalized mRNA treatment in addition to the immunotherapy treatment Keytruda. That number was just over 62% for those who only received the immunotherapy. Dr. Ryan Sullivan, associate director of the melanoma program at Mass General Hospital Cancer Center and a co-author of this new study, joined CBS News to talk about it.
#science #health #technology
CBS News Streaming Network is the premier 24/7 anchored streaming news service from CBS News and Stations, available free to everyone with access to the Internet. The CBS News Streaming Network is your destination for breaking news, live events and original reporting locally, nationally and around the globe. Launched in November 2014 as CBSN, the CBS News Streaming Network is available live in 91 countries and on 30 digital platforms and apps, as well as on CBSNews.com and Paramount+.
Subscribe to the CBS News YouTube channel: http://youtube.com/cbsnews
Watch CBS News: http://cbsn.ws/1PlLpZ7c
Download the CBS News app: http://cbsn.ws/1Xb1WC8
Follow CBS News on Instagram: https://www.instagram.com/cbsnews/
Like CBS News on Facebook: http://facebook.com/cbsnews
Follow CBS News on Twitter: http://twitter.com/cbsnews
Subscribe to our newsletters: http://cbsn.ws/1RqHw7T
Try Paramount+ free: https://bit.ly/2OiW1kZ
For video licensing inquiries, contact: licensing@veritone.com
-
Category
No comments found